Timber Pharmaceuticals, Inc.
TMBR · AMEX
12/31/2022 | 12/31/2021 | 12/31/2020 | 1/31/2020 | |
|---|---|---|---|---|
| Market Cap | $0 | $1 | $1 | $3 |
| - Cash | $9 | $17 | $10 | $0 |
| + Debt | $0 | $1 | $1 | $0 |
| Enterprise Value | -$8 | -$15 | -$9 | $3 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -71.9% | -34.8% | 39.8% | – |
| Gross Profit | -$13 | -$6 | -$1 | -$3 |
| % Margin | -15,892.4% | -1,979.4% | -230.8% | -942% |
| EBITDA | -$19 | -$10 | -$18 | -$0 |
| % Margin | -23,032.8% | -3,509% | -3,917.3% | -14% |
| Net Income | -$19 | -$11 | -$15 | -$4 |
| % Margin | -23,299% | -3,597.5% | -3,331.3% | -1,136.7% |
| EPS Diluted | -9.19 | -13.15 | -48.15 | -29.31 |
| % Growth | 30.1% | 72.7% | -64.3% | – |
| Operating Cash Flow | -$16 | -$9 | -$8 | -$1 |
| Capital Expenditures | -$0 | -$0 | -$1 | $0 |
| Free Cash Flow | -$16 | -$9 | -$9 | -$1 |